Parkinson’s Disease: A Neurodegenerative Disease

Journal Title: Journal of Clinical Medical Research - Year 2022, Vol 3, Issue 2

Abstract

Parkinson’s disease is characterized by tremor, stiffness, rigid muscles, bradykinesia, slowness of movement, instability leading to falls, memory and talking difficulties, fatigue, writing modifications (micrography) and dementia. In addition, depression, urinary (bladder) problems, constipation, decreased ability to smell and sleep disruption are among the symptoms associated to the PD. As Parkinson’s cannot be eradicate, treatments are oriented toward a slow decline and deterioration and therefore, only palliative care predominates. Mutations of 6 genes (SNCA, LRRK2, PRKN, DJ1, PINK1 and ATP13A2), are the cause of familial Parkinsonism. They are playing a role in the metabolism of α-synucleine, in mitochondrial control, oxidative stress, lysosomal functions, transport and recycling of proteins and immunologic activities. Five stages with increased gravity have been identified. From stage 1 to 3, symptoms may be treated with pharmacological drugs. At stages 4 and 5, the patient needs assistive help and an ambulatory walker device. L-dopa is transformed in dopamine in the brain. Treatments for speech disorders increase the disability of these symptoms. Dopamine agonists, MAO-B and COMT inhibitors contribute to help break down dopamine, an anticholinergic drug aiming to reduce tremors and muscle rigidity. Death is occurring within 7 to 15 years.

Authors and Affiliations

Michel Goldberg1*

Keywords

Related Articles

Hypomagnesemia: A Clinical Approach in Chronically Ill Patients with Multiple Comorbidities

Magnesium (Mg) is vital for many biochemical and physiological metabolic processes in the normally functioning human body physiology. Hypomagnesemia in hospitalized patients is particularly common among those with chroni...

Big Tobacco, Cigarettes and the Foundation of Duke University

Duke University was founded in 1930 primarily due to funds generated from James B Duke’s tobacco business. Duke achieved great financial wealth primarily due to the early application of machine rolled cigarettes, as oppo...

Sickle Cell Anemia: A Succinct Look into Recently Tested Disease Modifying Interventions

Sickle Cell Anemia (SCA) is a globally prevalent, monogenic, life-threatening blood disorder with a complex pathology that remains obscure. A deepened understanding of the malady in the recent years has led to pharmace...

The Importance of Chemistry in the Control of Doping in Sports during the Olympics

Chemical applications in the world of sports are diverse and of paramount importance for athletes to perform well. However, some of these athletes decide to use prohibited substances in order to obtain advantages against...

The Influence of Gene Mutations on Bone and Teeth: Osteogenesis and Dentinogenesis Imperfecta

Osteogenesis Imperfecta (OI) are inherited disorders generating skeletal fragility. It is caused by mutations in one of the two genes encoding type I collagen (COL-1A1, COL1A2). Four subtypes of OI has been identified:...

Download PDF file
  • EP ID EP704386
  • DOI http://dx.doi.org/10.46889/JCMR.2022.3203
  • Views 60
  • Downloads 0

How To Cite

Michel Goldberg1* (2022). Parkinson’s Disease: A Neurodegenerative Disease. Journal of Clinical Medical Research, 3(2), -. https://europub.co.uk/articles/-A-704386